Parc Taulí current affairs
This is a recognition from the Angelman Syndrome Foundation (ASF) for the comprehensive care that Parc Taulí offers to patients and families. read more
El Parc Taulí is one of the centers of reference for the diagnosis and follow-up of these patients from all over Spain. read more
The Parc Taulí Paediatrics Service has been participating, since last August, in an international clinical trial that aims to reverse the expression of the genetic defect of children with Angelman syndrome, which could lead to an important improvement in the symptomatology of patients diagnosed with this minority disease. This is a project promoted by the pharmaceutical company F. Hoffman-La Roche, which will have about 60 patients from all over the world, including 3 patients from Parc Taulí, with the intention of incorporating ne 3 more over the next few months. read more
When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.